Pharmaceutical Tablets

Product Details:

Imatero 400 mg is another formulation of Imatinib produced by Hetero Healthcare. Like the 100 mg version, Imatero 400 mg is used to treat certain cancers, primarily Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GISTs). The higher dose of 400 mg is typically used for patients requiring a stronger dose or for specific indications that require higher potency.

Imatinib, the active ingredient, works by inhibiting abnormal proteins that signal cancer cells to grow, helping to control the progression of these diseases. It’s crucial that the medication is prescribed and monitored by a doctor because of potential side effects and the need for regular testing.

Product Details:

Dyronib 50 mg is an anti-cancer medication manufactured by Hetero Healthcare, and its active ingredient is Dasatinib.
Dosage: Dyronib 50 mg tablets are typically taken orally as prescribed by your oncologist or healthcare provider. 
Side Effects: Common side effects can include fatigue, nausea, diarrhea, and changes in blood counts. It is important to monitor for any adverse reactions and report them to your doctor.